language_icon
EN
HI

Venus Remedies Share price

VENUSREM

1030.55

11.95 (-1.15%)
NSE
BSE
Last updated on 21 May, 2026 | 15:58 IST
Today's High

1055.00

Today's Low

1004.35

52 Week Low

331.50

52 Week High

1088.80

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Venus Remedies Chart

Venus Remedies Share Key Metrics

Volume
71894.00
Market Cap
1377.53 CR
LTQ@LTP
37@1030.55
ATP
1033.65
Var Margin
100 %
Circuit Range
990.4-1094.6
Delivery %
56.1 %
Value
7.43 CR
ASM/GSM
No
Market Lot
1

Summary

Venus Remedies share price is ₹1030.55 as of 22 May, 2026. The stock Venus Remedies intraday movement has stayed between ₹1004.35 and ₹1055.00, while on a 52-week basis,Venus Remedies price 52 week high is ₹1088.80 & its 52 week low is ₹331.50.
In terms of trading activity, Venus Remedies has recorded a volume of 71894 shares, The Venus Remedies has a market cap of ₹13366988 CR. The stock’s Average Traded Price (ATP) stands at ₹1033.65, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 37 @ ₹1030.55.
Venus Remedies operates within a circuit range of ₹990.40 – ₹1094.60, with a Value of ₹7.43 CR. The Delivery Percentage for the day is 56.1%. Additionally, Venus Remedies currently falls under the No framework, and trades with a market lot size of 1.

Venus Remedies Fundamentals

View More
P/E Ratio

18.29

P/B Ratio

2.25

Div. Yield

0

Sector P/E

71.81

Sector P/B

3.44

Sec. Div. Yield

0.55

Venus Remedies Resistance and Support

Pivot 1024.9

Resistance

First Resistance

1066.5

Second Resistance

1090.5

Third Resistance

1132.1

Support

First Support

1000.9

Second Support

959.3

Third Support

935.3

Venus Remedies Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

41.76%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

2.8%

Domestic Institutional Investors

1.2%

Retail

54.24%

Others

0%

Total Promoters
MAR '26
41.76%

Venus Remedies Corporate Actions

DateAgenda
2026-05-26Audited Results
2025-11-10Quarterly Results
2025-05-26Audited Results
2025-02-04Quarterly Results

Venus Remedies News

Venus Remedies Ltd - 526953 - Corporate Action-Board to consider Dividend

Venus Remedies board scheduled a meeting for May 26, 2026. The agenda includes consideration for a final dividend recommendation for FY26. Post-meeting, the board's decision on the dividend will be announced.
May 15 2026 15:05:00

Venus Remedies Ltd - 526953 - Board Meeting Intimation for Board Meeting Scheduled For 26Th May 2026.

Venus Remedies' Board of Directors will convene on May 26, 2026, to discuss and approve the audited financial results for the quarter and fiscal year ending March 31, 2026. They will also consider recommending a final dividend for the same period.
May 15 2026 15:05:00

About Venus Remedies

NSE : 13859  
BSE : 526953  
ISIN : INE411B01019  

M/s VENUS REMEDIES LTD. was incorporated as a privatelimited company on 15th day of Sept. 1989 in the name andstyle of Venus Glucose Pvt Ltd and subsequently convertedinto a public limited company vide fresh certificate ofincorporation dated 19th Sept. 1994 and the name wasconverted as "Venus Remedies Ltd" under the Companies Actissued by the Registrar of Companies Punjab HimachalPradesh and Chandigarh at Jalandhar. The company startedits production in the year 1991 withIntravenous/Intramuscular (IV/IM) injectable forms at itsrunning unit located at 52 Ind. Area. Phase-I PanchkulaDistt. Ambala (Haryana). Subsequently the companyintroduced Eye/Ear/Nasal Drops during the year 1994. Duringthe same year the company also expanded its existingcapacity from 9 lacs pieces per annum to 15 lacs pieces perannum and that of 9 lacs pieces to 20 lacs pieces per annumof IV fluids section and vial section respectively. Andduring 1994 the company has also certified as "WHO-GMP"(Good practices in manufacturing and quality control) asspecified by WHO Geneva by the State Drug Controller ofHaryana.MAIN OBJECTS OF THE COMPANYThe main objects of the company as set out in itsMemorandum of Association are :1. To manufacture import export of intravenous transfusionfluids and formations such as dextrose dextrose withsodium chloride normal saline isolate P isolate Misolate G isolate E Mannitol etc. in variousconcentrations intravenous solution for dialysis purposesACD Sterile bottles for blood collections pharmaceuticalparenteral preparations like AminophyllineAdernaline Water for injection Chloroquine SulphateSodium bi-carbonate Analgin Diazepam Oxyphenbutazone &other injectables.2. To carry on the business of deriving formulatingpurchasing producing manufacturing preparing processingmising compounding refining marketing distributingselling and trading in pharmaceuticals Chemicalscosmetics perfumes medicines and drugs of all kindsspecifications and descriptions and to do so especially inrespect of all kinds of analgesics and antipyretics.3. To carry on the business of purchasing producingmanufacturing preparing processing mixing compoundingrefining marketing distributing selling and trading inall classes and kinds of raw material ingredientsmixtures compounds and derivatives connected tointermediate in or associated with the manufactureproduction and sale of pharmaceuticals chemicals medicinesand drugs.4. To carry on the business of vialling bottling packing.repacking and processing of capsules syrups tabletsinjectables aerosoles and ointment bulk drugs andchemicals.

Read More

Venus Remedies Management

NamePosition
Pawan ChaudharyChairman & Managing Director
Manu ChaudharyJoint Managing Director
View More

Venus Remedies FAQs

The Buying Price of Venus Remedies share is 1030.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Venus Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Venus Remedies, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Venus Remedies shares is 18.29. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Venus Remedies shares is 2.25. Useful to assess the stock's value relative to its book value.

To assess Venus Remedies’s valuation compare Sector P/E, P/B which are 71.81 & 3.44 with sector averages, along with growth rates and financial metrics.

The Market Cap of Venus Remedies is 1377.53 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Venus Remedies share price is 1088.80 & 331.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Venus Remedies belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost